Canada markets closed

Kobayashi Pharmaceutical Co., Ltd. (KBYPF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
32.490.00 (0.00%)
At close: 03:32PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
161,873,000
173,455,000
166,258,000
155,252,000
150,514,000
Cost of Revenue
71,150,000
77,079,000
73,927,000
66,478,000
65,248,000
Gross Profit
90,721,000
96,375,000
92,331,000
88,773,000
85,265,000
Operating Expenses
Research Development
9,004,000
9,004,000
8,327,000
7,522,000
7,338,000
Selling General and Administrative
33,161,000
33,161,000
31,608,000
31,790,000
31,150,000
Total Operating Expenses
65,328,000
70,591,000
65,657,000
62,702,000
59,316,000
Operating Income or Loss
25,393,000
25,784,000
26,674,000
26,071,000
25,949,000
Interest Expense
18,000
29,000
18,000
18,000
21,000
Income Before Tax
27,114,000
27,559,000
27,950,000
27,636,000
26,635,000
Income Tax Expense
7,781,000
7,221,000
7,927,000
7,920,000
7,430,000
Income from Continuing Operations
19,333,000
20,338,000
20,023,000
19,716,000
19,205,000
Net Income
19,332,000
20,338,000
20,022,000
19,715,000
19,205,000
Net Income available to common shareholders
19,332,000
20,338,000
20,022,000
19,715,000
19,205,000
Basic EPS
275.75
-
259.63
252.36
245.71
Diluted EPS
275.71
-
259.59
252.36
245.71
Basic Average Shares
76,211
-
77,122
78,125
78,163
Diluted Average Shares
76,211
-
77,129
78,125
78,163